EU has not yet ordered more AstraZeneca COVID-19 vaccines, says official

Published: Updated:
Enable Read mode
100% Font Size

The European Union has not yet made any new orders for AstraZeneca vaccines beyond June when their contract ends, European Internal Market Commissioner Thierry Breton said on Sunday.

Breton also said he expected that the costs of the EU’s recent order for more doses of Pfizer-BioNTech vaccines would be higher than the earlier versions.

For more coronavirus news, visit our dedicated page.

The Commission last month launched legal action against AstraZeneca for not respecting its contract for the supply of COVID-19 vaccines and for not having a “reliable” plan to ensure timely deliveries.

“We did not renew the order after June. We’ll see what happens,” said Breton, adding that it was “a very good vaccine”

Concerns has risen on potential side-effects of the Anglo-Swedish COVID-19 vaccine.

For all the latest headlines follow our Google News channel online or via the app.

Europe’s medicines regulator said on Friday it is reviewing reports of a rare nerve-degenerating disorder in people who received the shots, a move that comes after it found the vaccine may have caused very rare blood clotting cases.

Breton said an increase in prices for second generation vaccines could be justified by the extra research required and potential changes to industrial equipment.

The European Union signed a new contract with Pfizer-Biontech to receive 1.8 billion doses of COVID-19 vaccines for 2021-2023, to cover booster shots, donations and reselling of doses, the European Commission said on Friday.

“There may be a little extra cost but I will let the competent authorities unveil it in due course,” he told France Inter radio.

Read more:

EU sues AstraZeneca for not respecting coronavirus vaccine supply contract

British medicine regulator cites 41 more blood clot reports following AstraZeneca jab

EMA reviews reports on rare nerve disorder after AstraZeneca vaccine

Top Content Trending